JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02248-06v1
81/7/3662    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larrea, E.
Right arrow Articles by Prieto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larrea, E.
Right arrow Articles by Prieto, J.

 Previous Article  |  Next Article 

Journal of Virology, April 2007, p. 3662-3666, Vol. 81, No. 7
0022-538X/07/$08.00+0     doi:10.1128/JVI.02248-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection{triangledown}

Esther Larrea,1,{dagger} José I. Riezu-Boj,1,{dagger} Lucía Gil-Guerrero,1,{dagger} Noelia Casares,1 Rafael Aldabe,1 Pablo Sarobe,1 María P. Civeira,2 Jonathan L. Heeney,3 Christine Rollier,3 Babs Verstrepen,3 Takaji Wakita,4 Francisco Borrás-Cuesta,1 Juan J. Lasarte,1,{ddagger}* and Jesús Prieto1,2,{ddagger}*

Division of Hepatology and Gene Therapy, Center for Applied Medical Research (CIMA), University of Navarra,1 Liver Unit, University Clinic, University of Navarra, CIBERedh, Pamplona, Spain,2 Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands,3 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan4

Received 13 October 2006/ Accepted 3 January 2007

Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan ratio (a reflection of IDO activity). Huh7 cells supporting hepatitis C virus (HCV) replication expressed higher levels of IDO mRNA than noninfected cells when stimulated with gamma interferon or when cocultured with activated T cells. In infected chimpanzees, hepatic IDO expression decreased in animals that cured the infection, while it remained high in those that progressed to chronicity. For both patients and chimpanzees, hepatic expression of IDO and CTLA-4 correlated directly. Induction of IDO may dampen T-cell reactivity to viral antigens in chronic HCV infection.


* Corresponding author. Mailing address: Division of Gene Therapy and Hepatology, Center for Applied Medical Research, CIMA, Avenida Pío XII, 55, 31008 Pamplona, Spain. Phone: 34 948 194700. Fax: 34 948 194717. E-mail for Juan José Lasarte: jjlasarte{at}unav.es. E-mail for Jesús Prieto: jprieto{at}unav.es.

{triangledown} Published ahead of print on 17 January 2007.

{dagger} E.L., J.I.R.-B., and L.G.-G. contributed equally to this work.

{ddagger} J. J. Lasarte and J. Prieto are senior authors of this article.


Journal of Virology, April 2007, p. 3662-3666, Vol. 81, No. 7
0022-538X/07/$08.00+0     doi:10.1128/JVI.02248-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.